Skip to main content
Brie Carter Photo
Brie Carter

Brie Carter

GrafaTV Presenter & Finance Editor

TV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.

Articles by Brie Carter

Grafa

BioCryst highlights efficacy gains across hereditary angioedema portfolio

BioCryst Pharmaceuticals (NASDAQ:BCRX) reported new clinical trial data and supportive real-world evidence evaluating its hereditary angioedema (HAE) portfolio at the European Academy of Allergy and Clinical Immunology (EAACI) 2026 Annual Meeting in Istanbul, Turkey.

Read more: BioCryst highlights efficacy gains across hereditary angioedema portfolio
Grafa

AbbVie presents nine-year data validating long-term benefits of fixed-duration Leukemia treatment

AbbVie (NYSE:ABBV) announced long-term follow-up results from its landmark Phase 3 CLL14 clinical trial, reinforcing the durable efficacy of its BCL-2 inhibitor Venclexta (venetoclax) when used as a fixed-duration therapy.

Read more: AbbVie presents nine-year data validating long-term benefits of fixed-duration Leukemia treatment
Grafa

LIXTE announces strategic transformation and pivot into AI energy infrastructure via acquisition of NOMAD

LIXTE Biotechnology (NASDAQ:LIXT) entered into a definitive agreement to acquire 100% of NOMAD Transportable Power Systems, executing a complete structural transformation away from its legacy clinical-stage oncology pipeline into a dedicated public-market platform for AI and utility energy infrastructure.

Read more: LIXTE announces strategic transformation and pivot into AI energy infrastructure via acquisition of NOMAD